Comparison between the efficacy of oxamniquine and praziquantel in the treatment ofSchistosoma mansoniinfections on a sugar estate in Ethiopia
Authors:
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 82 (2) , 175-180
Abstract
The efficacy of the antischistosomal drugs praziquantel and oxamniquine was tested on four groups of Ethiopian sugar estate workers. The cure rates, determined by the absence of eggs in stools, were 96, 93 and 74% at one, three and six months post-treatment for patients receiving a single dose (40 mg kg−1 body weight) of praziquantel, and 82, 78 and 78% for patients on a single dose (15 mg kg−1 body weight) of oxamniquine. When split doses of these drugs were used, praziquantel achieved cure rates of 96, 95 and 89%, while the corresponding cure rates for oxamniquine were 98, 96 and 88% at one, three and six months post-treatment. In general, there were no statistically significant differences within the single and split doses of each drug, nor between the two drugs except that single doses of praziquantel had significantly higher cure rates than oxamniquine at one and three months post-treatment. Although both drugs produced mild and transient side-effects such as dizziness, abdominal discomfort and diarrhoea, serious side-effects such as seizures were seen only among patients on oxamniquine. As praziquantel is also effective against other forms of schistosomiasis as well as against cestodes, we recommend the use of this drug in mass chemotherapy and in the ambulatory treatment of schistosomiasis in Ethiopia.Keywords
This publication has 3 references indexed in Scilit:
- Seizures Associated with Oxamniquine TherapyThe American Journal of Tropical Medicine and Hygiene, 1986
- PRELIMINARY CLINICAL-TRIAL OF ORAL OXAMNIQUINE IN THE TREATMENT OF SCHISTOSOMA-MANSONI IN ETHIOPIA1984
- A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, SudanPathogens and Global Health, 1983